Diabetes Therapy Access Physicians Working Group

The Diabetes Therapy Access Working Group is a unique network for clinicians interested in public policy surrounding access to therapies for diabetes.

As working group members know, the more than 29 million Americans diagnosed with diabetes represent a diverse cross section of the nation’s population.  The disease cuts across all ethnicities and age groups, affecting patients who also struggle with a range of related complications and co-morbidities.

A similarly diverse range of treatment options and medical devices exists to treat these patients.  In addition to lifestyle changes, patients may need rapid- or long-acting insulin, or some combination of the two.  To find a successful combination of treatments and approaches for each patient, physicians and patients need access to the full range of FDA-approved treatment options.  Health plan designs should facilitate, not impede, diabetes patients’ ability to make personalized health care decisions.

The Diabetes Therapy Access Working Group allows policy-minded endocrinologists and other health care providers to encourage informed decision-making on these and related issues.  Members identify access challenges and share their perspective with policymakers, the media and the public through education and advocacy initiatives.

Upcoming Events

Back to Top